Literature DB >> 17372678

Does the urokinase receptor exist in a latent form?

C Yuan1, M Huang.   

Abstract

Multiple cellular functions of urokinase and its receptor are associated with the receptor's capability to interact with a number of ligands at the molecular level. The presence of urokinase is generally needed for the urokinase receptor to acquire this capability. Recent X-ray studies of the structure of the urokinase receptor in complex with either its ligand or peptide inhibitors demonstrate the flexibility of the domain organization of the receptor, suggesting that unliganded urokinase receptor may exist in a latent form that has a conformation different from its ligand-binding form.

Mesh:

Substances:

Year:  2007        PMID: 17372678     DOI: 10.1007/s00018-007-6498-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  12 in total

1.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

2.  Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes.

Authors:  Qing Huai; Aiwu Zhou; Lin Lin; Andrew P Mazar; Graham C Parry; Jennifer Callahan; David E Shaw; Bruce Furie; Barbara C Furie; Mingdong Huang
Journal:  Nat Struct Mol Biol       Date:  2008-03-23       Impact factor: 15.369

3.  Challenges for drug discovery - a case study of urokinase receptor inhibition.

Authors:  Zhuo Chen; Lin Lin; Qing Huai; Mingdong Huang
Journal:  Comb Chem High Throughput Screen       Date:  2009-12       Impact factor: 1.339

4.  Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding.

Authors:  Daniel Miotto Dupont; Jeppe Buur Madsen; Roland Karl Hartmann; Bertrand Tavitian; Frédéric Ducongé; Jørgen Kjems; Peter André Andreasen
Journal:  RNA       Date:  2010-10-20       Impact factor: 4.942

5.  A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.

Authors:  Thore Hillig; Lars H Engelholm; Signe Ingvarsen; Daniel H Madsen; Henrik Gårdsvoll; Jørgen K Larsen; Michael Ploug; Keld Danø; Lars Kjøller; Niels Behrendt
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

6.  Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.

Authors:  Ali Munaim Yousif; Michele Minopoli; Katia Bifulco; Vincenzo Ingangi; Gioconda Di Carluccio; Francesco Merlino; Maria Letizia Motti; Paolo Grieco; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

7.  Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Authors:  Maria Vincenza Carriero; Katia Bifulco; Vincenzo Ingangi; Susan Costantini; Giovanni Botti; Concetta Ragone; Michele Minopoli; Maria Letizia Motti; Domenica Rea; Giosuè Scognamiglio; Gerardo Botti; Claudio Arra; Gennaro Ciliberto; Antonello Pessi
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

8.  The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.

Authors:  Vincenzo Ingangi; Katia Bifulco; Ali Munaim Yousif; Concetta Ragone; Maria Letizia Motti; Domenica Rea; Michele Minopoli; Giovanni Botti; Giuseppe Scognamiglio; Flavio Fazioli; Michele Gallo; Annarosaria De Chiara; Claudio Arra; Paolo Grieco; Maria Vincenza Carriero
Journal:  Oncotarget       Date:  2016-08-23

9.  Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.

Authors:  Michele Minopoli; Giovanni Botti; Vincenzo Gigantino; Concetta Ragone; Sabrina Sarno; Maria Letizia Motti; Giosuè Scognamiglio; Stefano Greggi; Cono Scaffa; Maria Serena Roca; Maria Patrizia Stoppelli; Gennaro Ciliberto; Nunzia Simona Losito; Maria Vincenza Carriero
Journal:  J Exp Clin Cancer Res       Date:  2019-11-08

10.  Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.

Authors:  Katia Bifulco; Immacolata Longanesi-Cattani; Paola Franco; Vincenzo Pavone; Pietro Mugione; Gioconda Di Carluccio; Maria Teresa Masucci; Claudio Arra; Giuseppe Pirozzi; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.